Statin Discontinuation in Nursing Home Residents with Advanced Dementia

Journal of the American Geriatrics Society

Volumn 62, Issue 11, 2014, Pages 2095-2101

  Tjia, Jennifer ^a   Cutrona, Sarah L ^a   Peterson, Daniel ^a   Reed, George ^a   Andrade, Susan E ^a   Mitchell, Susan L ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Hebrew Senior Life   (United States)

Author keywords

dementia; pharmaceuticals; statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADVANCED DEMENTIA; ARTICLE; CANCER DIAGNOSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEATH; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; EATING DISORDER; FEMALE; FOLLOW UP; HAZARD RATIO; HOSPICE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; QUALITY OF LIFE; RETROSPECTIVE STUDY; SAMPLE SIZE; UNITED STATES; AGED; ALZHEIMER DISEASE; CLASSIFICATION; COHORT ANALYSIS; COMORBIDITY; DISEASE COURSE; DRUG SUBSTITUTION; DRUG UTILIZATION; HOME FOR THE AGED; HOSPICE CARE; MENTAL HEALTH; NURSING HOME; RISK; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; COMORBIDITY; DEMENTIA; DISEASE PROGRESSION; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HOSPICE CARE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAL FUTILITY; MENTAL STATUS SCHEDULE; NURSING HOMES; ODDS RATIO; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84922480734     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13105     Document Type: Article

References (29)

1. Field M, Cassell C,. Institute of Medicine Report. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press, 1997.
2. Holmes HM, Sachs GA, Shega JW, et al., Integrating palliative medicine into the care of persons with advanced dementia: Identifying appropriate medication use. J Am Geriatr Soc 2008; 56: 1306-1311.
3. Mitchell SL, Teno JM, Kiely DK, et al., The clinical course of advanced dementia. N Engl J Med 2009; 361: 1529-1538.
4. Luchins DJ, Hanrahan P,. What is appropriate health care for end-stage dementia? J Am Geriatr Soc 1993; 41: 25-30.
5. Vollrath AM, Sinclair C, Hallenbeck J,. Discontinuing cardiovascular medications at the end of life: Lipid-lowering agents. J Palliat Med 2005; 8: 876-881.
6. Bayliss E, Bronsert MR, Reifler LM, et al., Statin prescribing patterns in a cohort of cancer patients with poor prognosis. J Palliat Med 2013; 16: 1-7.
7. Silveira MJ, Kazanis AS, Shevrin MP,. Statins in the last six months of life: A recognizable, life-limiting condition does not decrease their use. J Palliat Med 2008; 11: 685-693.
8. Currow DC, Stevenson JP, Abernethy AP, et al., Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590-595.
9. Blass DM, Black BS, Phillips H, et al., Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry 2008; 23: 490-496.
10. Tjia J, Rothman MR, Kiely DK, et al., Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 2010; 58: 880-888.
11. Tanvetyanon T, Choudhury AM,. Physician practice in the discontinuation of statins among patients with advanced lung cancer. J Palliat Care 2006; 22: 281-285.
12. Morris JR, Hawes C, Murphy K, et al., Resident Assessment Instrument Training Manual and Resource Guide. Natick, MA: Eliot Press, 1991.
13. Rahman AN, Applebaum RA,. The nursing home minimum data set assessment instrument: Manifest functions and unintended consequences-past, present, and future. Gerontologist 2009; 49: 727-735.
14. Morris JN, Fries BE, Mehr DR, et al., MDS cognitive performance scale. J Gerontol 1994; 49: M174-M182.
15. Avorn J, Gurwitz JH,. Drug use in the nursing home. Ann Intern Med 1995; 123: 195-204.
16. Doshi JA, Shaffer T, Briesacher BA,. National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc 2005; 53: 438-443.
17. Liperoti R, Mor V, Lapane KL, et al., The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003; 64: 1106-1112.
18. Snowden M, Sato K, Roy-Byrne P,. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: A review of the literature. J Am Geriatr Soc 2003; 51: 1305-1317.
19. Brauner DJ, Muir JC, Sachs GA,. Treating nondementia illnesses in patients with dementia. JAMA 2000; 283: 3230-3235.
20. Shaffer T, Simoni-Wastila L, Toler W, et al., Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries. J Am Geriatr Soc 2010; 58: 1549-1555.
21. Sampson EL, Blanchard MR, Jones L, et al., Dementia in the acute hospital: Prospective cohort study of prevalence and mortality. Br J Psychiatry 2009; 195: 61-66.
22. Teno JM, Mitchell SL, Gozalo PL, et al., Hospital characteristics associated with feeding tube placement in nursing home residents with advanced cognitive impairment. JAMA 2010; 303: 544-550.
23. Morrison RS, Siu AL,. Mortality from pneumonia and hip fractures in patients with advanced dementia. JAMA 2000; 284: 2447-2448.
24. Gaugler JE, Mittelman MS, Hepburn K, et al., Predictors of change in caregiver burden and depressive symptoms following nursing home admission. Psychol Aging 2009; 24: 385-396.
25. Epstein-Lubow G, Gaudiano B, Darling E, et al., Differences in depression severity in family caregivers of hospitalized individuals with dementia and family caregivers of outpatients with dementia. Am J Geriatr Psychiatry 2011; 20: 815-819.
26. Wright AA, Zhang B, Ray A, et al., Associations between end of life discussion, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673.
27. Bell CM, Brener SS, Gunraj N, et al., Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306: 840-847.
28. Boockvar K, Fishman E, Kyriacou CK, et al., Adverse events due to discon-tinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 2004; 164: 545-550.
29. Abernethy AP, Aziz NM, Basch E, et al., A strategy to advance the evidence base in palliative medicine: Formation of a palliative care research cooperative group. J Palliat Med 2010; 13: 1407-1413.